10
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Enterococcal Infections in a Greek Intensive Care Unit: A 5-y Study

Pages 275-280 | Published online: 08 Jul 2009

  • Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29: 19–24.
  • Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial aetiology of nosocomial infections. Am J Med 1991; 91 Suppl 3B: S72–5.
  • Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High level resistance to Gentamicin in Steptococcus faecalis: Risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986; 153: 1075–83.
  • Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; i: 57–8.
  • Morris JG, Jr, Shay DK, Hebden JN, McCarter RJ, Jr, Perdue BE, Jarvis W, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Ann Intern Med 1995; 123: 250–9.
  • Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin – United States, 1989–1993. MMWR 1993; 42: 597–9.
  • Mainous MR, Lipsett PA, O’Brien M. Enterococcal bacteremia in the surgical intensive care unit. Arch Surg 1997; 132: 76–81.
  • Rimalho A, Lampl E, Riou B, Richard C, Rottman E, Auzery P. Enteroccocal bacteremia in a medical intensive care unit. Crit Care Med 1988; 16: 126–9.
  • Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, Stobbering EE. Colonization and infection with Enterococcus faecalis in intensive care units: the role of antimicrobial agents. Antimicrob Agents Chemother 1995; 39: 2783–6.
  • Spencer RC. Epidemiology of infection in ICUs. Intensive Care Med 1994; 20: S2–6.
  • Wiederman B. Challengens of bacterial infections in European ICUs: Clinical Intensive Care 1996; 7 Suppl 6: 14–8.
  • Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in Intensive Care Units in Europe. JAMA 1995; 274: 639–44.
  • Vandamme P, Vercauteren E, Lammens C, Pensart N, Ieven M, Pot, et al. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996; 34: 2572–6.
  • Bell JM, Paton JC, Turnidge J. Emergence of vancomycin resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998; 36: 2187–90.
  • Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med 1996; 154: 617–24.
  • Allerberger F, Lass-Floerl C, Dierich MP, Hirschl AM, Presterl E, Haas G, et al. Vancomycin resistant entrrococci in Austria. Wiener Klinische Wochenschrift 1997; 109: 312–20.
  • Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40.
  • Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29.
  • Le Gall JR, Lemeshow S, Saulnier F. A New Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957–63.
  • National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA, 1993.
  • Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis Bacteremia: Acquisition and outcome. Clin Infect Dis 1995; 20: 296–301.
  • Burnett RJ, Haverstock DC, Dellinger P, Reinhart HH, Bohnen JM, Rotstein OD, et al. Definition of the role of enterococcus in intrabdominal infection: Analysis of a prospective randomized trial. Surgery 1995; 118: 716–21.
  • Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126–33.
  • Boyle JR, Soumakis SA, Rendo A, Herrington JA, Gianarkis DG, Thurberg BE, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 1280–5.
  • Suppola JP, Kuikka A, Vaara M, Valtonen V. Comparison of risk factors and outcome in patients with Enterococcus faecalis vs Enterococcus faecium bacteremia. Scand J Infect Dis 1998; 30: 153–7.
  • Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, et al. Epidemiology and mortality risk of vancomycin-resistant Enterococcal bloodstream infections. J Infect Dis 1995; 172: 993–1000.
  • McCarthy AE, Victor G, Ramotar K, Toye B. Risk factors for acquiring ampicillin-resistant Enterococci and clinical outcomes at a Canadian tertiary hospital. J Clin Microbiol 1994; 32: 2671–6.
  • Moellering RC, Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992; 14: 1173–8.
  • Liassine N, Frei R, Jan I, Auckenthaler R. Characterization of glycopeptide-resistant Enterococci from a Swiss hospital. J Clin Microbiol 1998; 36: 1853–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.